Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis, Relapsing-Remitting

Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.

455 public trials 46 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis, Relapsing-Remitting trial results

Completed

Extension Study to Evaluate Safety and Efficacy of Natalizumab in Japanese Participants With Relapsing-Remitting Multiple Sclerosis

NCT01416155

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site Chiba, Japan
  • Research Site Fukuoka, Japan
  • Research Site Hiroshima, Japan
  • Research Site Sapporo, Hokkaido, Japan
View all 22 locations
View Trial Details
Completed

Safety and Tolerability of Glatiramer Acetate

NCT01874145

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Teva Investigational Site 10706 Cullman, Alabama, United States
  • Teva Investigational Site 10719 Gilbert, Arizona, United States
  • Teva Investigational Site 10720 Phoenix, Arizona, United States
  • Teva Investigational Site 10727 Fresno, California, United States
View all 35 locations
View Trial Details
Completed

Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon Treatment

NCT00787657

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Many Locations, Argentina
  • Many Locations, Bahrain
  • Many Locations, Belgium
  • Many Locations, Bosnia and Herzegovina
View all 36 locations
View Trial Details

Related conditions